Search Results - "de Andrade, Michaela Larissa Lobo"

Brazilian experience with caplacizumab in acquired thrombotic thrombocytopenic purpura: outcomes of the expanded access program by de Oliveira Boechat, Tiago, de Holanda Farias, João Samuel, Ribeiro, Eduardo Flávio Oliveira, de Andrade, Michaela Larissa Lobo

“…Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease with an acute and severe clinical presentation. The anti-von Willebrand factor…”
Get full text

Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project) by Coppo, PAUL, Bubenheim, Michaël, Benhamou, Ygal, Voelker, Linus A., Brinkkoetter, Paul T., Kühne, Lucas, Knoebl, Paul N., Mingot, Maria Eva, Pascual Izquierdo, Maria Cristina, De La Rubia, Javier, Del Rio Garma, Julio, Chaturvedi, Shruti, Masias, Camila, Mazepa, Marshall, Zheng, X. Long, Sinkovits, Gyorgy, Reti, Marienn, Patriquin, Christopher J., Pavenski, Katerina, Boechat, Tiago, Farias, Joao, Ribeiro, Eduardo Flavio Oliveira, de Andrade, Michaela Larissa Lobo, Veyradier, Agnès, Joly, Bérangère, Bouzid, Raïda, Sakai, Kazuya, Matsumoto, Masanori, Mancini, Ilaria, Agosti, Pasquale, Peyvandi, Flora, Stubbs, Matthew James, Hmaid, Amjad, Sharif, Sobia, Dutt, Tina, Cataland, Spero, Lammle, Bernhard, Scully, Marie

“…Immune-mediated thrombotic thrombocytopenic purpura (iTTP) results from autoantibody-mediated severe deficiency of ADAMTS13, the Von Willebrand factor…”
Get full text